GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q3 2020 | $116,000 | -46.3% | 3,089 | -41.6% | 0.06% | -49.6% |
Q2 2020 | $216,000 | -13.6% | 5,288 | -20.0% | 0.12% | -24.3% |
Q1 2020 | $250,000 | -31.7% | 6,607 | -15.2% | 0.15% | -23.2% |
Q4 2019 | $366,000 | +11.6% | 7,790 | +0.3% | 0.20% | +1.0% |
Q3 2019 | $328,000 | +2.8% | 7,764 | -2.5% | 0.20% | -1.0% |
Q2 2019 | $319,000 | -8.3% | 7,960 | -4.3% | 0.20% | -16.5% |
Q1 2019 | $348,000 | +4.5% | 8,317 | -4.5% | 0.24% | -10.6% |
Q4 2018 | $333,000 | – | 8,705 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |